Back to News Releases
CONTACT: Jennifer Forbes
Communications & Public Affairs
732-235-6356, jenn.forbes@umdnj.edu
New Jersey Rheumatology Association Appoints Naomi Schlesinger, MD, as President
New Brunswick, NJ -- The New Jersey Rheumatology Association appointed Naomi Schlesinger, MD, a renowned international authority on gout, as president at its meeting on November 16. Dr. Schlesinger, an associate professor of medicine and chief of the division of rheumatology at UMDNJ-Robert Wood Medical School, will serve as president of the association for two years.
Dr. Schlesinger has authored more than 140 scientific papers, abstracts and chapters on the diagnosis, treatment and understanding of the pathogenesis of gout. She has helped to develop evidence-based medicine for gout within a framework of international committees that have defined various aspects of the disease, outlined the best modalities of treatment and assessed outcome measures in clinical trials. A clinician-scientist, Dr. Schlesinger is a leading international consultant and principal investigator along with her colleague, Professor Alexander So from Switzerland, for a novel therapy being tested internationally for the treatment of acute gout and the prevention of gout attacks.
A featured plenary speaker at the upcoming American College of Rheumatology Annual Scientific Meeting, Dr. Schlesinger will present her abstract on the prevention of flares in gout patients, which was chosen as one of the important abstracts of the year. She also served as a co-moderator and speaker at two additional sessions on gout during the meeting in Atlanta, GA, on November 10.
Dr. Schlesinger is a member of The Robert Wood Johnson Medical Group, the UMDNJ-Robert Wood Johnson Medical School’s multi-disciplinary faculty practice with approximately 500 physicians encompassing more than 200 sub-specialties, who have privileges at Robert Wood Johnson University Hospital. Through the partnership of Robert Wood Johnson Medical School and Robert Wood Johnson University Hospital, expert physicians have the significant resources of an academic medical center to ensure patients benefit from a comprehensive treatment program from diagnosis through rehabilitation.
About UMDNJ-ROBERT WOOD JOHNSON MEDICAL SCHOOL
As one of the nation’s leading comprehensive medical schools, UMDNJ-Robert Wood Johnson Medical School is dedicated to the pursuit of excellence in education, research, health care delivery, and the promotion of community health. In cooperation with Robert Wood Johnson University Hospital, the medical school’s principal affiliate, they comprise New Jersey’s premier academic medical center. In addition, Robert Wood Johnson Medical School has 34 other hospital affiliates and ambulatory care sites throughout the region.
As one of the eight schools of the University of Medicine and Dentistry of New Jersey with 2,800 full-time and volunteer faculty, Robert Wood Johnson Medical School encompasses 22 basic science and clinical departments, hosts centers and institutes including The Cancer Institute of New Jersey, the Child Health Institute of New Jersey, the Center for Advanced Biotechnology and Medicine, the Environmental and Occupational Health Sciences Institute, and the Stem Cell Institute of New Jersey. The medical school maintains educational programs at the undergraduate, graduate and postgraduate levels for more than 1,500 students on its campuses in New Brunswick, Piscataway, and Camden, and provides continuing education courses for health care professionals and community education programs. To learn more about UMDNJ-Robert Wood Johnson Medical School, log on to rwjms.umdnj.edu. Find our fan page at http://www.Facebook.com/RWJMS and follow us on Twitter www.twitter.com/UMDNJ_RWJMS.
#
